Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Ductal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Texas Health Science Center at Houston, Houston, Texas, United States
Contact: Study coordinator (Putao Cen, MD) · pancreasresearch@uth.tmc.edu · 832-325-7705
Contact: Study coordinator (Ayodeji Adeniji) · Ayodeji.Adeniji@uth.tmc.edu · (713) 500-5377

Study leads

Putao Cen
Principal Investigator
The University of Texas Health Science Center, Houston

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Colorectal Cancer · Pancreatic Ductal Adenocarcinoma · Biliary Tract Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Aurora, United States

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Pancreatic Ductal Adenocarcinoma · Gastric Cancer · Esophageal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Miami, United States · Miami, United States

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Pancreatic Ductal Adenocarcinoma (PDAC)

Abroad (travel likely)RecruitingPHASE2

St Louis, United States · New York, United States

Study for AZD4360 in Participants With Advanced Solid Tumours

Gastric Cancer · Gastroesophageal Junction Cancer · Biliary Tract Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Santa Monica, United States · Providence, United States